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Glial cells, the resident immune cells of the brain, are important for brain health; they perform 
critical protective functions following brain injury, during nervous system development, and to 
support general neuronal activity. Following brain injury, glia quickly respond by cleaning up 
neuronal and synaptic debris. In addition to their role as the cleaning cell of the brain, recent 
research has shown that during development, glia also shape and fine-tune neural connections by 
eliminating weak synapses fated for removal. However, whether glial cells also continue to remodel 
synaptic architecture in the adult brain is unclear. Moreover, synaptic loss is an early hallmark of 
Alzheimer’s disease (AD), but whether glial cells play a role in this pathophysiology remains 
mysterious. In this study, we investigate the role of glial cells in AD-related synaptic loss using a 
Drosophila melanogaster model of AD. Specifically, we will explore the role of the glial engulfment 
receptor Draper, which is essential for glial clearance of neuronal debris after injury, and evaluate 
its effect on synaptic loss in the AD fly model. For these studies, we will use immunohistochemistry 
and western blotting techniques, as well as the power of Drosophila genetics. Through this project, 
the effects of amyloid beta on synaptic molecule expression are assessed and the contribution of 



































Alzheimer’s disease (AD) is a progressive neurodegenerative disease, which is implicated by 
hallmark aggregations of extracellular amyloid beta protein. Mutations in the amyloid precursor 
protein (APP), causing a truncated version of the protein have been identified as a risk factor for 
Alzheimer’s disease (Goate et al. 1991; Citron et al. 1992). However, attention is also shifting to 
the immune cells of the brain called microglia. As the resident immune cells of the brain, they are 
actively surveying the brain parenchyma for injury (Nimmerjahn et al. 2005). Upon injury, they 
quickly respond, by changing their morphology and protein expression to engulf cellular and 
synaptic debris through active phagocytosis (Ivacko et al. 1996). In addition, microglia are critical 
for proper brain development as they shape synaptic connections during development. It has been 
shown that developing mice deficient for one essential microglial engulfment receptor displayed 
unrefined synaptic connectivity due to deficits in synaptic pruning (Paolicelli et al. 2011; Zhan et al. 
2014). 
 In Drosophila, the glial engulfment receptor Draper has been shown to be essential in glial 
engulfment of neuronal debris following injury (MacDonald et al. 2006). Upon axon injury, glial 
cells recruit their membranes at the site of injury and upregulate Draper. When Draper is knocked 
down or glial phagocytic activity is inhibited, axon fragments persist and are not cleared (Doherty 
et al. 2009). While Draper is specific to Drosophila, it is highly conserved and its mammalian 
homolog MEGF10 shows similar function in glial engulfment in mammals (Chung et al. 2013). This 
positions Draper as an essential and specific glial receptor for the interaction between glial cells 
and damaged/dying neurons and allows us to use the powerful Drosophila model to investigate 
conserved pathways.  
 In improving our understanding of Alzheimer’s disease, recent data suggests that amyloid 
beta aggregation is not the very first or critical molecular symptom of Alzheimer’s disease (Scheff 
and Price 2003). In mice, synaptic loss and dysfunction has been observed before any sign of 
hallmark aggregation (Yoshiyama et al. 2007), however whether glial cells are involved in this 
process is not clear. In addition, defects in glial cells have been shown to accumulate in the aging 
brain potentially leading to disease (Hanisch and Kettenmann 2007; 2010). We aim to validate a 
Drosophila model of Alzheimer’s Disease and create a timeline of when synaptic loss occurs in 
relation to neurodegeneration. Using this timeline, we will then be able to examine the role of glia 
in this process by investigating whether synaptic loss still occurs in the AD fly model when Draper 
is knocked out. By investigating the very initial pathophysiology observed in Alzheimer’s Disease 
and its associated signals, we hope to shed light on a potentially powerful mechanism to halt 




w+/-; elav-Gal4/ UAS-Aβarc; + 
w+/-; elav-Gal4/ w118; + 
w+/-; elav-Gal4/BRP-SNAP; UAS-Aβarc 
w+/-; elav-Gal4/ BRP-SNAP; + 
w+/-; elav-Gal4/ BRP-SNAP; Drpr Δ5 rec 9/UAS-Aβarc Drpr Δ5 rec 9 
Crosses were set up and maintained at 25o C. Flies were collected every 2 days (M, W, F) and 
incubated at 30o C.  
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Adult Fly Brain Fixation 
Fix Solution 1- 1x PBS, 0.01% Triton-X, 4% Paraformaldehyde 
Wash Solution 1- 1x PBS, 0.01% Triton X 
Fix Solution 2- 1x PBS, 0.1% Triton-X, 4% Paraformaldehyde 
Wash Solution 2- 1x PBS, 0.1% Triton X 
Adult flies from chosen groups were anesthetized and heads removed. Heads were fixed in Fix 
Solution 1 for 20 minutes with rocking. Heads were washed in wash solution 1 3 x 2 minutes. 
Brains were dissected in wash solution 1 in a standard dissection plate. Newly dissected brains 
were transferred to new tubes with wash solution 1. Wash solution 1 was pipetted out and replaced 
with Fix Solution 2. Brains were fixed for 20 minutes at room temperature with rocking. Brains 
were washed 3 x 2 minutes in wash solution 2.  
Antibody Staining 
Primary antibody master mixes were prepared at the following concentrations, diluting the antibody 
in wash solution 2: 
Mouse Anti-Draper 1:400; Guinea Pig Anti- Draper 1:400; Mouse Anti-Aβ 1:2000; Mouse Anti-
Bruchpilot 1:50. 
Secondary antibody master mixes were prepared at the following concentration, diluting the 
antibody in wash solution 2: 
Mouse 488 1:400; Guinea Pig 546 1:400 (Jackson Immuno). 
Brains were incubated in primary antibody with shaking at 4oC overnight. Brains were washed 4 x 
30 minutes in wash solution 2. Brains were then incubated in secondary antibody for 2 hours at 
room temperature with shaking and then washed 4 x 30 minutes in wash solution 2.  
BRP-SNAP Staining 
SNAP Tag mix was prepared at a concentration of 1 µM in 1x PBS with 0.3% Triton X. Brains were 
permeabilized for 1 x 10 min in 1x PBS with 0.3% Triton X for 10 min prior to staining. Brains were 
stained for 15 minutes at room temperature in a glass dissection dish with rocking. Brains were 
washed 1 x 5 min in 1x PBS & 0.3% Triton X and 1 x 5 min in 1x PBS. 
Mounting 
Brains were transferred to the glass well of a dissection dish and the wash solution was carefully 
removed with a pipette. A drop of Vectashield (Vector Labs) was then immediately dispensed onto 
the brains. Brains were incubated for 30 minutes at 4oC or overnight if desired. Slide preparation 
required placing a strip of clear tape onto a clean microscope slide. A template was used to trace 
and cut 4 wells into the tape. Brains were carefully transferred from the dissection dish to their 
appropriate well on the microscope slide. Excess Vectashield was carefully removed and brains 
were aligned and oriented with antennal lobes facing up. Small drops of Vectashield were added 
once all brains were oriented and a coverslip was gently dropped onto the wells. The coverslip was 
sealed around the border with a layer of CoverGrip (Biotium).  
Confocal Microscopy and Quantification 
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Images were taken on a Zeiss LSM 700 confocal microscope using a 40X oil immersion lens. For 
Draper staining, 11 slices through the Z plane were taken per brain at an interval of 1 µm. For 
Bruchpilot staining, 35 slices were taken through the Z plane at an interval of 0.5 µm.  
Quantification was completed using the Volocity software (Perkin & Elmer). For Draper staining, the 
5 slices, which depicted the same anatomical region in each sample, were quantified. Two standard 
circles were used to measure regions within the cortex above the antennal lobes. A threshold for 
background fluorescence was set in addition to a restriction of voxels 0.2 um in size or greater. For 
Bruchpilot staining, the 20 slices, which depicted the same anatomical region, were quantified. The 
antennal lobes were traced out, cropped and quantified. A threshold for background fluorescence 
was set in addition to a restriction of voxels 0.2 um in size or greater. Data was analyzed and 
graphed in GraphPad Prism 6.  
Western Blot Protocol 
Whole heads were pulled and collected in 1X loading buffer (10 heads per 30 uL of 1x loading 
buffer). Samples were homogenized using a pestle and centrifuged for 10 minutes at 4oC. 
Supernatant was collected and boiled for 10 minutes at 95oC and frozen at -80oC. 
10x running buffer was diluted to 1x and chilled at 4oc prior to use. 12 uL of sample was loaded 
into each well of a 10% Tris-HCl gel. 1.5 µL of protein ladder was loaded into edge lanes. Gel was 
run at a constant 125V for 2 hours.  
The wet transfer sandwich was prepared after the fiber pads, filter paper, and nitrocellulose 
membrane were soaked in transfer buffer. Gel sandwich was placed back in gel and ran at 100V for 
90 minutes.  
Membrane was soaked in methanol and then blocked with SEA Block (Calbiochem) for 30 min. 
Membrane was incubated overnight at 4oC with primary antibodies of the following concentrations: 
Rabbit Anti-Draper 1:2000 and Sheep Anti-Tubulin 1:4000. Membrane was washed 3 x 10 min in 
1xPBS-Tween. Secondary antibodies (Rabbit 790 1:2000 & Sheep 680 1:2000) were prepared in 
1X PBS and applied to membrane for 2 hours at room temperature. Membrane was washed 2x5 




Control: w+/-; elav-Gal4/ w118;  
Experimental: w+/-; elav-Gal4/ UAS-Aarc; +      
Flies show progressive Aβ accumulation in cortex 
In verification of our Drosophila model, brains were stained for Amyloid Beta which can be seen in 
cyan within the cortex (Figure 1). Control (w +/-; elav-Gal4/w118) flies showed no Amyloid Beta 
plaques. In addition, Amyloid Beta displays an increase in aggregation from the 1-3 D time point to 
the the later time point of 12-14 Days. Amyloid Beta was not quantified. Taken together, these 
initial results allow for a confirmation that our model system displays characteristic Alzheimer’s 





Figure 1: Flies show progressive Aβ aggregation in cortex. A) Elav-Gal4 UAS-Aarc 1-3 Days 
immunostained for Draper (magenta) and Amyloid Beta (cyan). B) Elav-Gal4 UAS-Aarc 12-14 
Days immunostained for Draper (magenta) and Amyloid Beta (cyan). 
 
Draper fluorescence is increased in young AB flies 
 
Whole brains were stained for Draper (Figure 2) and the Draper fluorescence within the cortex was 
quantified (Figure 3). The Draper fluorescence was elevated, although not significantly, in flies 
expressing the Aβ-arc mutation. This data suggests that Draper’s engulfment activity within glial 
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Figure 2: Draper fluorescence is increased in young A flies. A) Elav-Gal4 x Wt 1-3 Days 
after eclosion immunostained for Draper (green). B) Elav-Gal4 UAS-Aβarc 1-3 Day flies 
immunostained for Draper. n= 6-15. C)  Fluorescence within two standard circle regions within the 
cortex was quantified using Volocity software. n= 6-15. 
 
 
Synaptic fluorescence and density is decreased in young A flies 
 
To further delineate glial activity, synaptic levels were assessed via immunofluroescent staining 
targeting the synaptic protein Bruchpilot. Control flies displayed elevated fluorescence, although 





                                          
Figure 3: Synaptic density is decreased in young A flies. A) Elav-Gal4 x Wt anntenal lobe 
aged 1-4 days stained for Bruchpilot synaptic protein. B) Elav-Gal4 UAS-Aβarc aged 1-4 Days 
stained for Bruchpilot synaptic protein. n= 8-13. C) Fluorescence within antennal lobes was 




Draper protein is similary expressed in whole brains of WT and AD flies 
 
In order to more quantitatively assess Draper levels within the control and experimental groups, a 
Western Blot was performed to directly analyze protein levels. When quantfied and normalized 
against the corresponding total protein gel, Draper protein levels were similar amongst both control 
and experimental groups. This suggests that minimal differences exist in Draper protein expression 



































Figure 4: Western Blot of Draper and Tubulin. A) From left: Ladder, Lanes 1 & 2: Experimental 
1-3 Days, Lanes 3 & 4: Control 1-3 Days. Green band refers to Draper. Red band refers to Tubulin. 
B) Total protein gel served as loading/normalization control. C) Draper bands were quantified and 
normalized against corresponding lanes in total protein gel.  
 
         
Draper deficiency does not rescue synapses 
 
To ultimately evaluate whether Draper exerts some role on synaptic loss in the earliest stages of 
Alzheimer’s Disease, Draper null Aarc flies were examined for Bruchpilot fluorescence. Draper null 






Figure 5: Draper is not essential for AD synaptic loss. w +/-; elav-Gal4/BRP-SNAP; UAS-
Aβarc in left column; w +/-; elav-Gal4/ BRP-SNAP; Draper null/UAS-Aβarc Draper null in right 
column. Synapses were stained using a molecular probe against an endogenous SNAP-Tag 




Glial cells are a multi-faceted cell type playing essential roles in development, injury, and 
maintenance. Their significant contribution to the brain microenvironment makes them a prime 
candidate to investigate what effect they may have on early Alzheimer’s disease (AD), which is 
best characterized by synaptic loss that occurs before the onset of symptoms like memory loss. As 
glial cells are capable of pruning and engulfing synapses during development, this study aimed to 
investigate how glial cells may be involved in synaptic loss in the context of Alzheimer’s disease. 
More specifically, the highly conserved glial engulfment receptor Draper has previously been shown 
to be crucial for glial engulfment activity following neuronal injury (MacDonald et al. 2006; Doherty 
et al. 2009). Therefore, we hypothesized that Draper may also be upregulated and involved in AD 
related synaptic loss.  
 For this study, we used a Drosophila model of Alzheimer’s disease, in which human Aß is 
expressed pan-neuronally in the fly brain. In humans and mouse models of Alzheimer’s disease, 
this protein forms aggregates and leads to destruction of neurons. More specifically, the expressed 
Aß protein in our fly model contained the arctic mutation, which is known to cause severe protein 
aggregation in human disease (Nilsberth et al. 2001).  In our model, we observed the formation of 
Aß-aggregates in the fly brain shortly after eclosion, and they increased in size and number with 
age. In addition, we observed motor deficits in the Aß-expressing flies and a reduced lifespan 
compared to age-matched controls. The advantages of this model system in Drosophila are the 
ability to selectively express human Amyloid Beta in all neurons by utilizing the Elav-Gal4 UAS 
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system. The limitations are that the current model does not allow for adult specific Aβ expression. 
Instead, Aβ is expressed throughout development thereby quickly forming plaques after eclosion. 
This is in stark contrast to human Alzheimer’s Disease pathology which requires decades for Aβ 
plaques to form.  
 By utilizing immunohistochemistry techniques, Draper and the presynaptic protein 
Bruchpilot were visualized and quantified in both experimental Aß-expressing and age matched 
non-Aß expressing control groups. Bruchpilot staining revealed that synapses were decreased in 
young (1-4 Days) Aβ flies (Figure 3), while Draper staining in young (1-3 day old) Aβ flies showed 
an upregulation of Draper in the olfactory antennal lobe region of the adult fly brain (Figure 2). 
These studies suggested that Draper may play a role in glial cell mediated synaptic loss in AD. 
 To further investigate whether Draper is involved in early synapse loss in AD, an Aß-
expressing fly line in a Draper null mutation background was created. This allowed us to explore 
whether the removal of Draper would result in an increase or rescue of synapses. Staining with a 
fluorescent molecular probe against an endogenous SNAP-Tag attached to Bruchpilot allowed for 
more specific and thorough staining in a control group (w+/-; elav-Gal4/BRP-SNAP; UAS-Aßarc) 
and experimental Draper null group (w+/-; elav-Gal4/ BRP-SNAP; Draper null/UAS-Aßarc Draper 
null). This study revealed that Draper removal conferred no increase or rescue of synapses (Figure 
5). This preliminary data suggests that Draper is not essential in inducing synaptic loss in AD. 
However, this does not eliminate the possibility that glial cells contribute to synaptic loss. 
Alternative glial engulfment pathways such as the Crk/Mbc/dCed-12 may be implicated in synaptic 
loss. The Crk/Mbc/dCed-12 pathway acts in a semi non-redundant fashion downstream of Draper 
to actively phagocytose and uptake cellular debris (Ziegenfuss et al. 2012). While Draper is 
required for initial glial activation in response to injury, this study suggests that it is not the key 
player for AD-related synaptic loss. Other mediators in the glial engulfment pathway downstream 
of Draper, such as the Crk/Mbc/dCed-12 pathway, should be investigated in future research.  
 Although Draper was seen to be upregulated in young Aβ flies but does not rescue synaptic 
loss when knocked down, it may be upregulated for a myriad of other biological reasons. Glial cells 
are known to engulf Aβ plaques and prune synapses during development (Bolmont et al. 2008; 
Paolicelli et al. 2011; Chung et al. 2013) and this could be the reasons Draper upregulation was 
observed in our Drosophila AD model. Future work should include refining the AD model in 
Drosophila in order to better mimic the pathophysiology of AD. For example, in our experimental 
group, Aß was expressed throughout development and plaques form a few days after eclosion. In 
order to create a more realistic AD model, Aβ could be expressed strictly in adult flies without 
perturbing development. This may model the human age-related disease more closely. This may be 
accomplished through the use of a weaker neuronal driver than Elav-Gal4, or through genetically 
inhibiting Aß expression during the fly’s development.   
 In conclusion, this study provides a preliminary depiction of the role of Draper in glial 
mediated synaptic loss in the context of AD. Further research would include repeating these 
experiments and investigating other engulfment pathways which may be implicated in the earliest 
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